JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

85 hedge funds and large institutions have $39M invested in Jounce Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$6K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.67M
2
$4.73M
3
$4.05M
4
$3.64M
5
$2.85M
6
$2.03M
7
$1.84M
8
$1.81M
9
$1.62M
10
$1.55M
11
$1.22M
12
$744K
13
$720K
14
$580K
15
$536K
16
$494K
17
$422K
18
$396K
19
$384K
20
$339K
21
$307K
22
$306K
23
$278K
24
$251K
25
$176K